纪念何炳林教授诞辰100周年学术报告

报告题目：Octopus Solves the Magic: A journey of a nanocarrier from cancer to sepsis

报告人：Juntao Luo, Ph.D.
             Assistant Professor
             Department of Pharmacology, SNYT Upstate Cancer Center, SUNY Upstate Medical University

报告时间：2018年4月12日上午9:00

报告地点：南开大学蒙民伟楼 201

Publications：

  1.       Luo J. T.*; et al. A drug-specific nanocarrier design for efficient anticancer therapy. Nat.  Commun., 2015, 6, 7449.

  2.       Luo J. T.*; et al. Well-Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to Acidic pH Values and cis-Diols. Angew.  Chem. Int. Edit., 2012, 51, 2864.

  3.       Luo J. T.*; et al. Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment. Cancer Res., 2017, 77, 3293.

  4.       Luo J. T.*; et al. "OA02" Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo. Cancer Res., 2012, 72, 2100.

  5.       Luo J. T.*; et al. Tunable Lipidoid-Telodendrimer Hybrid Nanoparticles for Intracellular Protein Delivery in Brain Tumor Treatment. Small, 2016, 12, 4185.

  6.       Luo J. T.*; et al. Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy. Biomaterials, 2017, 141, 161.

  7.       Luo J. T.*; et al. Affinity-controlled protein encapsulation into sub-30 nm telodendrimer nanocarriers by multivalent and synergistic interactions. Biomaterials, 2016, 101, 258.

  8.       Luo J. T.*; et al. Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials, 2015, 37, 456.

  9.       Luo J. T.*; et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials, 2011, 32, 6633.

10.  Luo J. T.*; et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials, 2011, 32, 3435.

11.  Luo J. T.*; et al. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.  Biomaterials, 2009, 30, 6006.

12.  Luo J. T.*; et al. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. J. Controlled Release, 2011, 155, 272.